Study shows depression increases disability risk in rheumatoid arthritis sufferers

The interactions between rheumatoid arthritis (RA) and major depressive disorder (MDD).

FDA grants ODD to Abdera’s neuroendocrine carcinoma treatment

The biologic therapy is created to deliver the radioisotope 225Ac to tumours expressing the DLL3 protein. Credit: Kateryna Kon/Shutterstock. The US Food and Drug Administration

September 6, 2024

Freedom Biosciences Announces FDA Approval of IND Application for FREE001 in Patients with Treatment-Resistant Depression | Psychedelic Invest

SAN FRANCISCO, April 25, 2024 /PRNewswire/ — Freedom Biosciences, Inc. (“Freedom Bio” or the “Company”), a clinical-stage biotechnology platform focused on developing next-generation neuropsychiatric therapeutics, today announced that the U.S.

May 1, 2024

Otsuka sees highest filings and grants during July in Q3 2023

Share this article Otsuka has been focused on protecting inventions in Japan(JP) with 61 publications in Q3 2023 The Japan(JP) Patent Office dominates the patent

December 11, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.